Statins × lipids

TrialCardiology2016

Icosabutate, a Structurally Engineered Fatty Acid, Improves the Cardiovascular Risk Profile in Statin-Treated Patients with Residual Hypertriglyceridemia.

John J P Kastelein et al.PubMed ↗Publisher ↗

What the trial testedas reported · 140 people · 2016

No range given

Reported lower lipids, no range given

−7.40percentage points

As reported

difference −7.4 %, no interval

One number in the abstract

the abstract, start to end

for a between-group difference of -7.4% (p = 0.02).

← favours treatmentfavours comparator →
could be chance
No interval given · direction only, strength unknown
Lipids
−7.4
StatinsLipids

Statins × lipidshelps?mixed

unlikelylikely
0.500.78 without it
← favours comparatorfavours treatment →
this papermore certainless certain
1 / 5

7 papers cite it

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 27160246